We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.425 | 4.63% | 9.60 | 9.40 | 9.80 | 9.40 | 9.00 | 9.00 | 2,228,014 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 475k | -8.27M | -0.0142 | -6.62 | 54.88M |
TIDMETX
RNS Number : 0871K
e-Therapeutics plc
23 August 2019
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 1. Identity of the issuer or the e-Therapeutics PLC underlying issuer of existing shares to which voting rights are attached: (ii) 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): --------------------------------------------------------------- 3. Full name of person(s) subject Rupert Labrum to the notification obligation: (iii) 4. Full name of shareholder(s) (if different from 3.): (iv) -------------- 5. Date of the transaction and date 22/08/2019 on which the threshold is crossed or reached: (v) -------------- 6. Date on which issuer notified: 23/08/2019 -------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5.00% -------------- 8. Notified details: A: Voting rights attached to shares (viii, ix) Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE --------------------- -------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights (x) Shares Voting Rights ---------- --------- ----------- -------------------- --------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ---------- --------- ----------- --------- --------- --------- ---------- GB00B2823H99 12015000 12015000 13449017 13449017 5.0% ---------- --------- ----------- --------- --------- --------- ---------- B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion rights that rights Period (xiv) may be acquired if the instrument is exercised/ converted. ------------- -------------- ----------------------- ------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) Resulting situation after the triggering transaction Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date (xvii) Conversion rights instrument rights (xix, period refers to xx) (xviii) --------- ------------- ------------ ------------------- ---------------- Nominal Delta --------- ------------- ------------ ------------------- -------- ------ Total (A+B+C) Number of voting rights Percentage of voting rights ---------------------------- 13449017 5.0% ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: 14. Contact name: Rupert Labrum --------------- 15. Contact telephone number: ---------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLEAEPDAFPNEFF
(END) Dow Jones Newswires
August 23, 2019 06:21 ET (10:21 GMT)
1 Year E-therapeutics Chart |
1 Month E-therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions